MALVERN, Pa., Oct. 22, 2019 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it plans to release third quarter 2019 financial and operating results, and certain guidance for the fourth quarter and full year 2019, prior to market open on Tuesday, November 5, 2019. Chris Thatcher, Chief Executive Officer, and Stephen Furlong, Chief Financial Officer, will host a conference call to review the Company’s results at 8:30 a.m. Eastern Time the same day. The call will be concurrently webcast.To listen to the conference call on your telephone, please dial (877) 472-8990 for United States callers or +1 (629) 228-0778 for international callers and reference confirmation code 3946759, approximately ten minutes prior to start time. To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Neuronetics’ website at ir.neuronetics.com. The replay will be available on the Company’s website for approximately 60 days.Investor Contact:
Mark R. Klausner
Westwicke Partners 
443-213-0501
[email protected]Media Contact:
Leanne Scott Brown
Vault Communications
610-455-2742
[email protected]
Bay Street News